HB 682 — Prohibit certain insurance practices
Last action — Referred to committee
-
1Introduced
-
2In Committee
-
3Passed House
-
4Passed Senate
-
5To Executive
-
6Enacted
This bill has been introduced in the House. Introduced February 04, 2026. It must pass committee before a floor vote.
Next likely step: a committee referral and hearing.
Prognosis
Where this bill stands today.
Odds of enactment
LowHow often bills like it became law.
Not enough signal yet to read this bill's trajectory — we surface a likelihood only once there's real movement (stage, sponsorship, committee, or votes) to point to.
Prognosis reads this bill's own signals — stage, sponsorship breadth, committee status, recorded votes and cross-state momentum. Odds come from a model trained on which bills have become law.
In plain language
The bill prohibits certain insurance practices for physician-administered drugs in specific medical cases.
This bill aims to prohibit specific insurance practices that affect how physician-administered drugs are provided to patients with certain serious medical conditions. It focuses on ensuring access to these medications for those with chronic, complex, rare, or life-threatening conditions.
What this means for you
- Families: Families of patients with serious conditions may face fewer hurdles in accessing essential medications.
- Healthcare: This means healthcare providers may have more flexibility in administering necessary drugs to patients.
Summary
To enact section 3902.65 of the Revised Code to prohibit certain insurance practices related to physician-administered drugs for patients with chronic, complex, rare, or life-threatening medical conditions.
Bill Text
- Introduced As Introduced Current pdf
Action History
-
As Introduced
Sponsors
- Meredith Craig · Primary
Sponsorship breakdown
Export CSV (upgrade) →1 sponsors · 0 co-sponsors · 133 not signed on
Sponsors (1)
- Meredith Craig Republican
Co-sponsors (0)
None.
Not signed on (133)
133 members have not signed on to this bill.
Show all 133 →"Not signed on" means a member has not sponsored or co-sponsored this bill — it does not imply opposition. Members flagged Voted No have a recorded No vote on this bill.
Subjects
Frequently asked questions
- What does HB 682 do?
- To enact section 3902.65 of the Revised Code to prohibit certain insurance practices related to physician-administered drugs for patients with chronic, complex, rare, or life-threatening medical conditions.
- Who sponsors HB 682?
- HB 682 is sponsored by Meredith Craig (Republican).
- What is the current status of HB 682?
- This bill has been introduced in the House. Introduced February 04, 2026. It must pass committee before a floor vote.
- Where can I track HB 682?
- Track HB 682 free on One Click Politics — get push/email alerts when it moves.
Make your voice heard on HB 682
Find the representatives who decide this bill and tell them where you stand — for yourself, or mobilize your whole list in one click with One Click Politics advocacy software.
Stay ahead of HB 682
Last checked for changes 3 months ago · updated continuously
One Click Politics tracks every bill in Congress and all 50 states.
Track this bill →